Josh Disbrow

Insider profile

Currently holds positions in Aytu Biopharma Inc and Zynex Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 20% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Aytu Biopharma Inc Jan. 27, 2016 -
Independent Director Zynex Inc March 5, 2018 -
Chief Executive Officer Aytu Biopharma Inc April 16, 2015 - Jan. 27, 2016
Chief Operating Officer Ampio Pharmaceuticals Inc Dec. 15, 2012 - April 16, 2015
Josh Disbrow's trades of Aytu Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
233.33
Quantity 45,124 +16.4%
Value US$3,608,380
Transaction date
Purchase
Price
127.69
Quantity 84,432 +30.2%
Value US$1,359,464
US Zynex Inc (ZYXI)
Transaction date
Purchase
Price
256.52
Quantity 77,125 +25.3%
Value US$452,969
Transaction date
Purchase
Price
1.86
Quantity 14,000 +24.3%
Value US$26,079
Transaction date
Purchase
Price
0.22
Quantity 112,371 +10.0%
Value US$25,047
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-10 2025-06-09
B Purchase
45,124 +16.4%
233.33
US$3,608,380 		45,124 +16.4% 233.33 US$3,608,380
2025-03-03 2025-02-28
B Purchase
84,432 +30.2%
127.69
US$1,359,464 		84,432 +30.2% 127.69 US$1,359,464
2024-07-30 2024-07-29
US Zynex Inc (ZYXI)
B Purchase
77,125 +25.3%
256.52
US$452,969 		77,125 +25.3% 256.52 US$452,969
2023-06-15 2023-06-14
B Purchase
14,000 +24.3%
1.86
US$26,079 		14,000 +24.3% 1.86 US$26,079
2022-12-21 2022-12-19
B Purchase
112,371 +10.0%
0.22
US$25,047 		112,371 +10.0% 0.22 US$25,047